Background: Low lung function is known to predict mortality in the general population, but the prognostic significance of emphysema on computed tomography (CT) in persons without chronic obstructive pulmonary disease (COPD) is uncertain.
C
hronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States and globally (1, 2) . It is defined physiologically as airflow obstruction on spirometry that does not completely reverse (3) . Most medical therapies and almost all randomized clinical trials in COPD target the airways. Such therapies alleviate symptoms and reduce hospitalizations but have not been proved to affect disease progression or reduce mortality (4 -7) .
Pulmonary emphysema is defined anatomically as destruction of lung parenchyma and loss of intra-alveolar walls (8, 9) . It was originally diagnosed on autopsy but can also be assessed via chest computed tomography (CT), which is now recommended as a screening tool for lung cancer among high risk groups (10 -12) .
Emphysema is common in the general population; autopsy studies show that most smokers and up to 10% of never-smokers have some degree of the disease (13) . Emphysema on CT is a common "incidental" finding that occurs in 29% of smokers undergoing lung cancer screening (14) and 4% of healthy adults having cardiac scanning (15) . Furthermore, emphysema and COPD overlap less than previously believed: Emphysema is frequently observed in the absence of COPD (16 -18) , and approximately half of patients with COPD do not have substantial emphysema (19) .
Although reduced lung function is known to be associated with increased all-cause mortality in the general population (20 -22) , and although emphysema on CT may portend a worse prognosis in patients with COPD (16, 23) and in selected smokers (14, 24) , the prognostic importance of emphysema on CT among patients without COPD and in the broader population of smokers and nonsmokers is unknown. We therefore examined the associations between the extent of emphysema-like lung on CT and mortality among persons who had no airflow obstruction on spirometry (and were therefore free of COPD) in a large, multiethnic, population-based cohort followed for 6 years after spirometry. We studied both smokers and never-smokers because panlobular emphysema is prevalent in both populations (13, 17) . race/ethnicity in 2000 to 2002 (25) . Exclusion criteria were history of clinical cardiovascular disease, weight greater than 136 kg (Ͼ300 lb) (the maximum for CT scanners at the time), and impediments to long-term participation. Participants were recruited from Forsyth County, North Carolina; northern Manhattan and the Bronx, New York; Baltimore City and Baltimore County, Maryland; St. Paul, Minnesota; Chicago, Illinois; and Los Angeles, California. Five participants were excluded from follow-up after discovery of prebaseline cardiovascular events, and 12 were missing valid CT measurements (Appendix Figure 1 , available at www.annals.org).
Follow-up and Mortality
Interviewers contacted each MESA participant or a family member to inquire about vital status every 9 to 12 months. The National Death Index (NDI) was also regularly reviewed to ensure complete follow-up for mortality through the most recent NDI update (31 December 2010). Death from any cause was the primary end point.
Emphysema-like Lung
All MESA participants had cardiac CT at baseline according to standardized protocols on either electron-beam or multidetector CT scanners (26) in 2000 to 2002. For each participant, 2 scans were done at suspended full inspiration from the carina to the lung bases with transverse fields of view that captured the whole lung field. These scans captured an average of 65% of the total lung volume on full-lung scans acquired in a validation study (27) in MESA (Figure 1 and Appendix Table 1 , available at www .annals.org).
Image attenuation was assessed by using a modified version of the Pulmonary Analysis Software Suite (28, 29) at a single reading center by trained readers without knowledge of other participant information. Emphysema-like lung was defined as the number of lung voxels with outside air-corrected attenuation less than Ϫ950 Hounsfield units (HU) based on pathologic comparisons (30) on the scan with higher air volume or, in the case of discordant quality scores, the higher-quality scan (27) (Appendix Figure 2  and Appendix Table 2 , available at www.annals.org). To correct for variations in scanner calibration and in the way different scanners handle scatter and beam hardening, we measured the attenuation of air outside the body, which should have a mean attenuation of Ϫ1000 HU, for each scan in a region distant from the body and scanner table. The outside air-corrected attenuation of each lung pixel was defined as (measured pixel attenuation) ϫ (Ϫ1000/ mean outside-air attenuation).
Regions of the lung with features suggestive of interstitial lung abnormalities (high-attenuation areas) were defined as the number of lung voxels with attenuation between Ϫ600 and Ϫ250 HU (31). All of these measures were previously validated against those obtained from fulllung scans in MESA (r ϭ 0.93 for emphysema-like lung) (27, 31) .
Spirometry
Spirometry was attempted between 2004 and 2006 for 3965 participants who had baseline measurements of endothelial function (99% of MESA sample), consented to genetic analyses (99% of MESA sample), and had an examination during the MESA Lung Study recruitment period (Appendix Figure 1) . A total of 3847 participants performed maneuvers in accordance with the joint guidelines from the American Thoracic Society and European Respiratory Society (32) on a dry rolling-seal spirometer (Occupational Marketing); results were reviewed by a single investigator (33) .
Airflow obstruction was defined as an FEV 1 -FVC ratio less than 0.70, in accordance with current guidelines (3) . Absence of airflow obstruction on prebronchodilator spirometry when this definition is used effectively excludes COPD, which is defined as a postbronchodilator FEV 1 -FVC ratio less than 0.70 (3). An FEV 1 -FVC ratio less than the lower limit of normal (34) was used to define airflow obstruction for a secondary analysis.
Covariates
Age, sex, race/ethnicity, educational attainment, cancer history, physician diagnoses of emphysema and asthma, intentional exercise per week, alcohol use, and tobacco use were self-reported at baseline. Never smoking was defined as a lifetime smoking history of fewer than 100 cigarettes, and current smoking was defined as cigarette use within the past 30 days. Urine cotinine was measured for a subset of 3929 participants; 78 (2%) who denied current smoking but had urine cotinine levels greater than 100 ng/mL were reclassified as current smokers. Pack-years were calculated as (cigarettes per day/20) ϫ (years smoked).
Height; weight; systolic and diastolic blood pressures; and levels of total and high-density lipoprotein cholesterol,
Context
The clinical significance of emphysematous changes in the lung sometimes seen on computed tomography (CT) in patients who do not have chronic obstructive pulmonary disease is uncertain.
Contribution
This study examined mortality among participants without airflow obstruction on spirometry who did and did not have emphysematous changes in the lungs on cardiac CT. Emphysematous lung changes on CT were associated with increased mortality, particularly among smokers.
Implication
Understanding the significance of an incidental finding of emphysematous lung will be increasingly important as the use of CT expands in such areas as lung cancer screening and cardiac calcium scoring.
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Original Research Emphysema-like Lung on CT and All-Cause Mortality creatinine, D-dimer, C-reactive protein, and fasting plasma glucose were measured by using standard techniques (25, 35) . Medication use was assessed by validated medication inventory (36) .
A phantom-adjusted coronary artery calcium Agatston score (37) was calculated from each cardiac CT scan, and the mean of the 2 values was used as previously described (38) .
Statistical Analysis
Statistical tests were based on multivariable-adjusted Cox proportional hazards models and additive Cox models with penalized splines. We used the latter approach to test and account for any potential nonlinearity in associations and to generate plots.
The study sample comprised participants with valid spirometry measures who did not have airflow obstruction. We calculated survival time as age at death or, for nondeceased participants, age at last follow-up or the most recent NDI update, whichever occurred later, with left truncation at age at spirometry.
We confirmed the proportional hazards assumption via interaction terms with time (P Ͼ 0.100). The number of emphysema-like voxels was first adjusted for total imaged lung voxels. We then sequentially adjusted the analyses for CT scanner type and tube current, site, baseline age, sex, race/ethnicity, weight, height, educational attainment, smoking status and pack-years, alcohol use, coronary artery calcium Agatston score, diabetes medication use, insulin use, fasting glucose level, hypertension, antihypertensive medication use, systolic and diastolic blood pressures, cholesterol medication use, total and high-density lipoprotein cholesterol levels, creatinine level, history of cancer, and FEV 1 . To account for potential confounding by subclinical interstitial abnormalities, models were adjusted for highattenuation areas. The full model was subsequently adjusted for potential mediators (exercise, C-reactive protein level, and D-dimer level). We used multiple imputation to account for missing covariate data, which were infrequent (6% for pack-years and Ͻ1% for all other covariates). Effect estimates were calculated per one-half interquartile range (IQR) for emphysematous voxels because the distribution was skewed to the right.
All primary analyses were stratified by smoking status. For additional potential effect modifiers (age, race/ethnicity, body mass index [BMI], sex, scanner type, and site), multiplicative interaction terms and within-strata effect estimates were tested in fully adjusted models. We performed sensitivity analyses among participants without selfreported emphysema or asthma, and using alternative definitions of airflow obstruction.
The effect of CT emphysema measures on discrimination of incident all-cause mortality was tested in logistic models and assessed via improvements in the c-statistic.
We performed all statistical analyses in SAS, version 9.2 (SAS Institute), or R (R Foundation for Statistical Computing) (39) .
Role of the Funding Source
MESA was funded by the National Heart, Lung, and Blood Institute (NHLBI). The study was approved by NHLBI as well as the institutional review boards of all collaborating institutions. All participants gave written informed consent. Together with MESA investigators, the authors collected and analyzed the data, vouched for the data and analysis, and wrote this paper and submitted it for publication. The NHLBI staff routinely monitored study 
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RESULTS
The 2965 participants without airflow obstruction on valid spirometry had a mean age at CT scan of 60 years; 32.5% were white, 25.6% were African American, 25.1% were Hispanic, and 16.8% were Asian, and 12.1% were current smokers, 37.0% were former smokers, and 50.9% were never-smokers ( Table 1) .
Participants with more emphysema-like voxels were predominantly male, were more likely to be white, had higher educational attainment, and were more likely to have smoked cigarettes (Appendix Tables 3 and 4, available at www.annals.org).
Emphysema-like lung was modestly correlated with the percentage of predicted FEV 1 (r ϭ 0.11) and the FEV 1 -FVC ratio (r ϭ Ϫ0.08) among all participants with spirometry after we controlled for total imaged lung volume, scanner characteristics, and site (P Ͻ 0.001 for each).
All-Cause Mortality
There were 186 deaths among the 2965 participants over a median of 6.2 years after spirometry, which corresponds to a mortality rate of 10.0 per 1000 person-years. Vital status was known for 100% of these participants.
Participants Without Airflow Obstruction
Emphysema-like lung was associated with all-cause mortality ( Table 2 and Appendix Table 5 , available at www.annals.org). In the fully adjusted linear model, an increase in emphysema-like voxels equivalent to half of the IQR was associated with a 14% greater mortality rate Voxels with attenuation less than Ϫ950 HU divided by total imaged lung voxels. ¶ Voxels with attenuation between Ϫ600 and Ϫ250 HU divided by total imaged lung voxels. (Figure 2) .
By Smoking Status
Relationships between emphysema-like lung and allcause mortality were of greatest magnitude among the relatively small subset of current smokers, statistically significant among former smokers, and positive but nonsignificant among never-smokers ( Table 2 and Appendix Table 5). Evaluation of multiplicative interaction terms did not provide evidence for significant effect modification by smoking status (P ϭ 0.95). Although additive models strongly supported a linear association between emphysematous voxels and all-cause mortality among smokers, nonlinearity was a consideration among never-smokers (P for nonlinearity ϭ 0.130) (Figure 3) .
Sensitivity Analysis and Mortality Prediction
Effect estimates were broadly consistent across strata of age, race/ethnicity, BMI, CT scanner type, and site, and the corresponding multiplicative interaction terms were not statistically significant (Table 3) , although findings were attenuated in overweight and obese persons.
There was also no evidence for interaction by sex (Table 3), although effect estimates were significant among men but close to the null among women, who accounted for 65% of never-smokers (Appendix Table 6 Excluding participants with self-reported emphysema (n ϭ 13) and self-reported asthma (n ϭ 217) did not alter effect estimates (HR per half-IQR, 1.13 [CI, 1.03 to 1.24]; P ϭ 0.011).
Findings were also similar among participants without airflow obstruction defined by the lower limit of normal for the FEV 1 -FVC ratio (n ϭ 3378) (HR per half-IQR, 1.09 [CI, 1.01 to 1.18]; P ϭ 0.035). In this sample, there was no evidence for an effect modification by smoking status (HR per half-IQR, 1.08 among both never-smokers and former smokers; P for interaction term ϭ 0.35) or sex (HR per half-IQR, 1.08 for women and 1.06 for men; P for interaction term ϭ 0.24).
Emphysema-like lung nonsignificantly improved the prediction of all-cause mortality compared with a full model that included demographic factors, body size, smoking, and other risk factors (c ϭ 0.791 vs. 0.786), as did the FEV 1 (c ϭ 0.791). Addition of emphysematous voxels and the FEV 1 to the full model provided borderline incremental benefit (c ϭ 0.795).
DISCUSSION
Emphysema-like lung assessed quantitatively on CT was associated with increased all-cause mortality among persons without airflow obstruction or COPD on spirometry in a large, population-based, multiethnic cohort. This association was independent of many potential confounders, including FEV 1 , and persisted among participants without physician-diagnosed emphysema or asthma. Findings were of greater magnitude among former and current smokers than among never-smokers. These findings suggest that "subclinical" emphysema among patients without spirometrically defined COPD is clinically relevant.
The prognostic value of emphysema on CT is of general interest because of the relatively high population prevalence of emphysema (40) , the paucity of research on the clinical significance of emphysema (as opposed to spirometrically defined COPD), and the rapid growth in the use of chest CT for lung cancer screening and assessment of coronary artery calcium (10 -12, 41 ). Yet, to our knowledge, no prior studies have examined the prognostic significance of emphysema on CT in a population-based sample, among patients without COPD, or among nonsmokers. Prior small studies of patients with ␣1-antitrypsin deficiency (42), patients with very severe COPD (24), and Japanese and Norwegian patients with COPD (16, 23) Original Research Emphysema-like Lung on CT and All-Cause Mortality showed significant associations between emphysema-like lung on CT and all-cause mortality, whereas an Italian lung cancer screening trial did not (43) . However, none of these prior studies were powered to examine emphysemalike lung on CT in participants without spirometrically defined COPD. Increased death rates from COPD and lung cancer have been associated with radiologist-scored emphysema on CT from a lung cancer screening cohort of heavy smokers (14) , although covariate adjustment in that study was limited, preexisting diagnoses were not considered, and spirometry was not done. Furthermore, visual scoring can have low rates of agreement between radiologists (44), can be insensitive for panlobular emphysema (45) , and is relatively time-consuming compared with quantitative approaches.
Mechanisms by which emphysema may contribute to premature death due to respiratory causes in patients with and without COPD include direct physiologic effects of loss of lung parenchyma and vasculature. This loss reduces the area available for gas exchange, which may be associated with hypoxemia, poor exercise capacity, and reduced functional status (46) . Loss of alveolar walls also contributes to untethering of airways, loss of radial traction forces, and reduction in airway caliber (47) . This may contribute to airflow obstruction (48, 49) that may be intermittent, producing functional limitation during exacerbations but not necessarily meeting the standard clinical definition of COPD (3). Indeed, emphysema-like lung on CT has recently been shown to be associated with respiratory exacerbations and hospitalizations among smokers independent of FEV 1 (50) . Other mechanisms linking emphysema to all-cause mortality include increased susceptibility to pulmonary infections (51) , impaired cardiac function (52) resulting in reduced cardiopulmonary reserve, and systemic inflammation (53) .
Unlike prior studies, the present study, which was drawn from the general population, included a large number of participants who had never smoked cigarettes. Prior literature has indicated that emphysema-particularly panlobular emphysema-is only modestly associated with smoking, as shown on autopsy (13), on CT scans in patients with COPD (17, 54) , and in the current cohort (55) . Nonetheless, compared with the strong and consistent associations observed among smokers, findings among never-smokers were modest and did not attain statistical significance, although neither did the statistical test for effect modification by smoking history. Associations between emphysema-like lung and mortality were consistent across smoking strata among men but were more variable among women. The latter results were probably due to chance, given the small number of events among women. Other considerations include measurement error due to reduced cardiac CT scan coverage among women (Appendix Table  1 ) or underestimation of emphysema-like lung attributable to breast artifact, consistent with the finding of congruent 
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Emphysema-like Lung on CT and All-Cause Mortality www.annals.orgeffects for men and women after exclusion of overweight participants. Alternatively, the findings may reflect differences in emphysema prevalence and biology according to smoking or sex (13, 56, 57) . Regions of emphysema-like lung are unlikely to simply be markers of increased cumulative tobacco exposure. In addition to the aforementioned (albeit tentative) findings in never-smokers and the weak association of pack-years with emphysema on CT, analyses were adjusted for cotinineconfirmed smoking history with little attenuation of results. Also, current smoking artifactually diminishes detection of emphysema-like voxels (58) , which means that misspecification of smoking would bias results conservatively.
Spirometry was only available for a subset of participants, was acquired after baseline, and did not include postbronchodilator measures. Nonetheless, we found statistically significant associations among participants without airflow obstruction. These analyses were conservative from a clinical perspective because almost no patients with COPD have normal prebronchodilator spirometric results, whereas one third of patients with airflow obstruction on prebronchodilator spirometry do not meet clinical postbronchodilator criteria for COPD (59) .
MESA cardiac CT scans did not image the lung apices, the primary anatomical location of tobacco-associated centrilobular emphysema. Lack of such imaging is therefore likely to have caused an underestimate of the quantity of emphysema-like lung, particularly among smokers, which may have led to an underestimation of risk, although the validation study sample (27) was not large enough to definitively determine the direction of this potential bias. Variability in cardiac CT scan coverage was slightly greater among racial minorities and obese participants (Appendix Table 2 ), which may explain the larger effect estimates observed among white and normal-weight BMI ϭ body mass index; CT ϭ computed tomography; HR ϭ hazard ratio; IQR ϭ interquartile range. * Emphysema-like lung was parameterized as emphysematous voxels. Airflow obstruction was defined as an FEV 1 -FVC ratio Ͻ0.70 on spirometry. All covariates except FEV 1 were measured at the baseline examination in 2000 to 2002. Numbers may not sum to totals due to rounding. † One IQR is equivalent to 91 809 voxels. Models were adjusted for a multiplicative interaction term (emphysematous voxels ϫ stratum), total imaged lung volume, scanner type and milliamperes, site, age, sex, race/ethnicity, educational attainment, height, weight, coronary artery calcium Agatston score, cardiac risk factors, creatinine level, cancer history, alcohol use, FEV 1 , and high-attenuation areas.
Original Research Emphysema-like Lung on CT and All-Cause Mortality participants. Nevertheless, emphysema-like lung on cardiac scans showed high correlation with measures from fulllung scans in MESA (27) . Because cardiac CT scans are done for cardiovascular risk stratification, results from such scans have clinical value in and of themselves. We did not examine specific emphysema subtypes, which have shown associations with symptoms and physiology among smokers (17) . Automated methods for CT emphysema subtype determination are still in development (60, 61) and are not available for cardiac CT. Nonetheless, findings in never-smokers, the excellent visualization of the lower lungs, and results from a genome-wide association study of percentage of emphysema in this cohort that showed associations for variants in genes highly relevant to ␣1-antitrypsin metabolism (62) suggest that emphysemalike lung on cardiac CT scans may preferentially detect panlobular emphysema.
We performed statistical tests based on linear terms for percentage of emphysema because absolute values depend on scanner and protocol factors, making categorized results from these scans less generalizable. However, scanner and technology standardization are forthcoming (63) , and results were not driven by outliers.
Neither emphysema-like voxels nor the FEV 1 significantly improved the prediction of all-cause mortality. This is unsurprising given that age accounts for 94% of the variance in this important but nonspecific end point.
We did not evaluate emphysema-like lung according to the BODE Index (64) because the index was specifically designed for patients with COPD, who were excluded. However, we adjusted for its major components: BMI (parameterized as height and weight), obstruction (FEV 1 ), and exercise tolerance (self-reported intentional exercise; 6-minute walking distance was not available). We did not adjust for its fourth component, dyspnea, because it is a likely consequence of emphysema.
In conclusion, greater emphysema-like lung on CT was independently associated with higher all-cause mortality among participants without airflow obstruction in a multiethnic, population-based sample. Results persisted among participants without clinical disease. Associations were more consistent among smokers, but harmful associations among never-smokers could not be excluded. These findings suggest that emphysema confers excess risk independent of spirometrically defined COPD. Clinical appreciation of the prognostic implications of emphysema on CT and investigation of therapies specifically targeting emphysema, of which there are none, are warranted. 
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